touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing.
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/treatment-sequencing-in-ms-the-benefits-of-dmts/
Part 1 - Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals
Experts in infectious diseases discuss the practical considerations for COVID-19 vaccination in Africa
Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management
Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management
Clinical updates from SGO 2023 on PARP inhibitors in ovarian cancer
Improving outcomes in pulmonary arterial hypertension: A multidisciplinary approach
Improving outcomes in pulmonary arterial hypertension: A multidisciplinary approach
ICI-based combinations for advanced/metastatic renal cell carcinoma: Highlights from ASCO GU 2023
Blood-based biomarkers: Supporting the diagnosis and treatment of Alzheimer’s disease
Reducing transmission of COVID-19 Spotlight on vaccines
Personalized treatment of advanced HER2-negative gastric or gastroesophageal junction cancer: Current status and future perspectives
Optimizing strategies for the treatment of colorectal cancer in the biomarker era - Modules 1 & 2
Improving outcomes of immune-related adverse events: The crucial role of the pharmacist
Optimizing patient outcomes in Cushing’s disease
Treatment pathways with a focus on medical therapies for Cushing’s disease
Managing Cushing’s disease and goals of medical therapy
Optimizing strategies for the treatment of colorectal cancer in the biomarker era - Module 1
MDT perspectives on novel approaches to overcome resistance with standard-of-care immunotherapy for non-driver mutation metastatic NSCLC
MDT perspectives on tracking prognostic and predictive biomarkers for immunotherapy
MDT and patient perspectives on shared decision making for emerging treatment options
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
The Psychic Elephant Radio Podcast
Museum of the Missing
Sasquatch Chronicles
Hidden Brain